share_log

Streamline Health Solns Q2 EPS $(0.07), Inline, Sales $5.99M Beat $5.20M Estimate

Streamline Health Solns Q2 EPS $(0.07), Inline, Sales $5.99M Beat $5.20M Estimate

Streamline Health Solns第二季度每股收益0.07美元,內聯,銷售額599萬美元超過預期520萬美元
Benzinga Real-time News ·  2022/09/07 16:12

Streamline Health Solns (NASDAQ:STRM) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. The company reported quarterly sales of $5.99 million which beat the analyst consensus estimate of $5.20 million by 15.23 percent. This is a 108.93 percent increase over sales of $2.87 million the same period last year.

Streamline Health Solns(納斯達克股票代碼:STRM)公佈季度虧損為每股0.07美元,符合分析師的普遍預期。該公司公佈的季度銷售額為599萬美元,比分析師普遍預期的520萬美元高出15.23%。這比去年同期287萬美元的銷售額增長了108.93個百分點。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論